Daishin Balance No.6 Special Purpose Acquisition Co. Ltd (307750) fair value: what the stock is really worth
As of Sep 23, 2026: fair value of Daishin Balance No.6 Special Purpose Acquisition Co. Ltd KRW 2,084, price KRW 2,250, upside -7.4%, quality 48 out of 100. Calculated from audited financials with 26 valuation models and 37 quality factors, updated daily.
Watch Daishin Balance No.6 Special Purpose Acquisition Co. Ltd for free, get notified when fair value or trend changes. Plus fair value for all 35,000+ stocks, 14 days of Pro free, no card.Watch for freePro now: $1 first month
69 individual criteria per stock, every one traceableSee the method →
Price vs Fair Value
White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Sep 24, 2026.
How to read this chart
60‑month range 1,800 KRW – 21,947 KRW · fair‑value band 1,309 KRW – 3,040 KRW · the 2,250 KRW price screens above the 2,084 KRW fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). Dashed = 300-day average. As of Sep 24, 2026.
Follow Daishin Balance No.6 Special Purpose Acquisition Co. in your weekly email
Every Wednesday you see whether Daishin Balance No.6 Special Purpose Acquisition Co. is on track or worth a review, plus price against fair value. Free, up to 3 stocks.
We send you a confirmation link. Unsubscribe with one click.
Kookjeon Pharmaceutical Co., Ltd. operates as a chemical total solutions provider in South Korea. It provides various chemical-based products and services; and after-sales services, such as research and development, production, quality control, and DMF services.
Show more
Kookjeon Pharmaceutical Co., Ltd. operates as a chemical total solutions provider in South Korea. It provides various chemical-based products and services; and after-sales services, such as research and development, production, quality control, and DMF services. The company manufactures active pharmaceutical ingredients; and offers molecular design and technical support. It develops electronic materials, such as antistatic agents, monomers and polymers with low dielectric constant, and UV curing agents; low-resistance electrolyte, phosphine, silane, and boron compounds; semiconductor materials; and carbazole, boric acid, and fluorene intermediates. In addition, the company owns patents for its manufacturing methods. It serves pharmaceuticals, intermediate products, new drug synthesis, and related materials industries. The company was founded in 1972 and is headquartered in Anyang-si, South Korea.
Stock analysis
Daishin Balance No.6 Special Purpose Acquisition Co. Ltd (307750) currently trades at 2,250 KRW, while our model-based Fair Value estimate is 2,084 KRW, implying the stock looks roughly 8.0% fairly valued today.
Show more
Valuation
Bull case: the Growth DCF group reads highest at a median of 2,147 KRW per share, and 2 of the 10 models we run sit above the 2,250 KRW price.
Bear case: the Multiples group reads lowest at 542.50 KRW, and 8 of the 10 models stay below the price. Evidence for this calculation is medium.
Scenario range: 1,309 KRW (bear) to 3,040 KRW (bull), the price of 2,250 KRW sits inside it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.
Quality & growth
The Quality Score stands at 48/100 (below-average quality), in the Healthcare sector.
Mixed Growth: Revenue is growing, but margins or cash flow do not fully confirm the trend.
Daishin Balance No.6 Special Purpose Acquisition Co. Ltd reported revenue of 131B KRW in FY2025 versus 85.4B KRW in FY2021, a compound +11.3%/yr. Reported net income was −4.3B KRW in FY2025.
Key figures
Market cap 113B KRW (≈ $83.0M) · P/S ratio 0.87 · Dividend yield 0.4% · Net margin −3.3% · Return on equity −7.9% · Return on assets (EBIT) 1.6% · Operating margin 7.7% · Revenue (TTM) 127B KRW.
Competitive moat
Our AI-assisted moat analysis scores the competitive advantage at 38 out of 100 (low confidence).
What moves the price
The share trades about 59% below its 52-week high and 25% above its 52-week low, currently below its 200-day average.
For context, the median of 10 Healthcare peers we cover trades at 1% fair-value upside, at −7%, 307750 screens richer than that median.
Fair Value models
Bear 1,309 KRWFair Value 2,084 KRWBull 3,040 KRW
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above is their evidence-weighted blend, not the output of a single model.Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target.Evidence ⓘEvidence = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card.47/100
Revenue is growing, but margins or cash flow do not fully confirm the trend.
Revenue growth 1 year
−4.0%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+8.1%
Revenue growth 5 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+10.2%
Start year 2020 (pandemic)
’20
’21
’22
’23
’24
’25
Profit margin (trend) ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.
7.2% (2020) → −2.0% (2025)
What shareholders gained per year ⓘWe only publish this rate when it is defensible. Reason: fiscal 2025 is a loss year, no rate is defined from a loss
not computed
Growth Forecast
Price in line with expectations
The price assumes about as much growth as the company has delivered so far.
What the price assumes ⓘThis turns our valuation around: instead of asking what the share is worth, it asks what growth the current price requires. It uses the cash the company keeps after all spending (free cash flow), the same discount rate as our models, five years of growth, then slowing evenly to 2 % a year by year ten. Compared with the analysts' sales forecasts extended to the same five years (at least three analysts, for context only, it does not enter the Fair Value): within 3 percentage points counts as "in line" (amber), below that little optimism (green), above that a lot of optimism (red).
+11.7%
Yearly growth needed for the next five years to justify today's price.
What forecasts expect
n/a
No analyst forecast available.
After inflation (South Korea: IMF forecast 2.1% a year to 2030, 2.1% from 2016 to 2025) that is about +9.4% a year for the price.
Compare Daishin Balance No.6 Special Purpose Acquisition Co. Ltd with another stock
Price, fair value, quality and upside side by side.
Free, no sign-up
Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Drug Manufacturers - General · 74 stocks
Beats the industry median on 3/10 measures
Overall it trails its industry peers.
Valuation
Quality Score48 · Below median
Fair Value upside−7% · Above median
Profitability
Return on assets0% · Bottom 25%
Net margin (TTM)−6% · Bottom 25%
Operating margin (TTM)8% · Below median
Growth and dividend
Revenue growth−9% · Bottom 25%
Dividend yield (TTM)0.4% · Bottom 25%
Balance sheet
Debt / equity0.16× · Above median
Valuation Multiplesvs Drug Manufacturers - General median · lower = cheaper
For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.
Cite: Fair Value Calculator (2026). "Daishin Balance No.6 Special Purpose Acquisition Co. Ltd Fair Value". https://www.fairvalue-calculator.com/stock/307750
Frequently asked questions
Is Daishin Balance No.6 Special Purpose Acquisition Co. Ltd (307750) overvalued or undervalued?
As of Sep 24, 2026, our model estimates a fair value of 2,084 KRW versus a price of 2,250 KRW, about −7% upside (fairly valued).
What is the fair value of 307750?
Our model-based fair value for Daishin Balance No.6 Special Purpose Acquisition Co. Ltd is 2,084 KRW (as of Sep 24, 2026), built from audited fundamentals. The current price: 2,250 KRW.
What is the quality score of 307750?
Daishin Balance No.6 Special Purpose Acquisition Co. Ltd has a Quality Score of 48/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for Daishin Balance No.6 Special Purpose Acquisition Co. Ltd (307750)?
Our model-based price target is the fair value of 2,084 KRW (as of Sep 24, 2026) from 10 valuation models. Cautious scenario 1,309 KRW, optimistic scenario 3,040 KRW. It is a calculation from audited fundamentals, not an analyst target.
What is the Daishin Balance No.6 Special Purpose Acquisition Co. Ltd stock forecast for 2026?
Our models put fair value at 2,084 KRW, about −7% upside versus a price of 2,250 KRW (fairly valued). Cautious scenario 1,309 KRW, optimistic scenario 3,040 KRW. The calculation is refreshed regularly with new filings.
What is the revenue of Daishin Balance No.6 Special Purpose Acquisition Co. Ltd (307750)?
Daishin Balance No.6 Special Purpose Acquisition Co. Ltd reported trailing-twelve-month revenue of about 127B KRW (latest available figure, as of Sep 24, 2026).
Does Daishin Balance No.6 Special Purpose Acquisition Co. Ltd pay a dividend?
Daishin Balance No.6 Special Purpose Acquisition Co. Ltd currently shows a dividend yield of about 0.44% relative to its recent price (as of Sep 24, 2026).
What growth is priced into Daishin Balance No.6 Special Purpose Acquisition Co. Ltd (307750)?
For today's price to be fair in a discounted-cash-flow model, Daishin Balance No.6 Special Purpose Acquisition Co. Ltd would have to grow free cash flow by +11.7 % per year for five years (discount rate 13.1 %, then slowing evenly to 2 % perpetual growth by year ten). Over the last 5 years revenue grew +10.2 % per year. As of Sep 24, 2026.
What discount rate (WACC) does the fair value of 307750 use?
Our models discount Daishin Balance No.6 Special Purpose Acquisition Co. Ltd at 13.1 %: a base by market capitalisation (micro), country premium for South Korea. The same rate applies in all 26 models.
What is a reverse DCF?
A reverse DCF turns the usual calculation around. Instead of deriving a value from assumptions, it takes today's price as given and asks: what free-cash-flow growth would a company have to deliver for exactly this price to be fair? The result is not a forecast but the expectation already priced in. For Daishin Balance No.6 Special Purpose Acquisition Co. Ltd that is +11.7 % per year a year over ten years, using the same discount rate (13.1 %) and the same formula as our fair value.
How much growth has Daishin Balance No.6 Special Purpose Acquisition Co. Ltd (307750) delivered so far?
Over the past 5 years revenue at Daishin Balance No.6 Special Purpose Acquisition Co. Ltd grew +10.2 % a year. The price currently implies +11.7 % per year free-cash-flow growth a year. Comparing the two shows how much confidence is in the price: if it demands more than has been delivered, the business has to accelerate for the maths to work.
How fast is the sector of Daishin Balance No.6 Special Purpose Acquisition Co. Ltd (307750) growing?
The median revenue growth in the sector is +1.9 % a year. That is the yardstick for the growth priced into Daishin Balance No.6 Special Purpose Acquisition Co. Ltd (+11.7 % per year a year): it shows whether the expectation is within the usual range or beyond it.
What is the free cash flow yield of Daishin Balance No.6 Special Purpose Acquisition Co. Ltd (307750)?
The free-cash-flow yield on the price is 6.58 %: that much free cash flow Daishin Balance No.6 Special Purpose Acquisition Co. Ltd produces per unit of market value. When it exceeds the discount rate of our models (13.1 %), the business already earns more than its cost of capital demands, and the price needs little additional growth.
What is the intrinsic value of Daishin Balance No.6 Special Purpose Acquisition Co. Ltd (307750)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For Daishin Balance No.6 Special Purpose Acquisition Co. Ltd it is 2,084 KRW per share (as of Sep 24, 2026), against a price of 2,250 KRW. It is the blended result of 10 valuation models (cash flow, earnings, asset, dividend).
Is Daishin Balance No.6 Special Purpose Acquisition Co. Ltd stock overvalued or undervalued in 2026?
As of Sep 24, 2026, 307750 trades above its calculated fair value: price 2,250 KRW, fair value 2,084 KRW, a gap of about −7% (fairly valued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of 307750?
No. The price is what the market pays today (2,250 KRW); the fair value is what the company's own numbers justify (2,084 KRW). For Daishin Balance No.6 Special Purpose Acquisition Co. Ltd the two are 166.28 KRW per share apart. That gap is exactly why we show both numbers side by side.
How much is Daishin Balance No.6 Special Purpose Acquisition Co. Ltd worth?
The market values Daishin Balance No.6 Special Purpose Acquisition Co. Ltd at about 113B KRW (market capitalisation, as of Sep 24, 2026). Per share that is 2,250 KRW; our models calculate a fair value of 2,084 KRW per share.
What do the bullish and bearish scenarios say about 307750?
Our models span a range for Daishin Balance No.6 Special Purpose Acquisition Co. Ltd: cautious scenario 1,309 KRW, base 2,084 KRW, optimistic 3,040 KRW per share (as of Sep 24, 2026, price 2,250 KRW). The range comes from different growth and margin assumptions, not from analyst opinions.
How solid is the balance sheet of Daishin Balance No.6 Special Purpose Acquisition Co. Ltd (307750)?
Balance-sheet figures for Daishin Balance No.6 Special Purpose Acquisition Co. Ltd (as of Sep 24, 2026): return on equity −7.9%, debt of 0.16 per unit of equity. They feed the Quality Score of 48/100, which measures business quality independently of the share price.
How far is 307750 from its 52-week high?
Daishin Balance No.6 Special Purpose Acquisition Co. Ltd trades at 2,250 KRW, about 59% below its 52-week high of 5,540 KRW and 25% above the low of 1,800 KRW (as of Sep 23, 2026). Distance from the high says nothing about value: that is what the fair value of 2,084 KRW is for.
Which stocks are comparable to Daishin Balance No.6 Special Purpose Acquisition Co. Ltd?
From the same area (Healthcare) we also value Eli Lilly and Company, Johnson & Johnson,, AbbVie Inc, Roche Holding, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is Daishin Balance No.6 Special Purpose Acquisition Co. Ltd stock attractive at the current price?
The data as of Sep 24, 2026: price 2,250 KRW, calculated fair value 2,084 KRW (−7%), Quality Score 48/100, from 10 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of 307750 calculated?
We run Daishin Balance No.6 Special Purpose Acquisition Co. Ltd through 10 models from four families: discounted cash flow, earnings models, asset and balance-sheet models, and dividend models. Every model gets the same audited fundamentals; the result is the weighted average of 2,084 KRW, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 14.0 % above its aggregate fair value. Daishin Balance No.6 Special Purpose Acquisition Co. Ltd itself currently trades above fair value. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of Daishin Balance No.6 Special Purpose Acquisition Co. Ltd (307750)?
The closing price on Sep 23, 2026 was 2,250 KRW. Our model-based fair value is 2,084 KRW, about −7% upside (fairly valued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with Daishin Balance No.6 Special Purpose Acquisition Co. Ltd right now?
The price sits close to our fair value, market and models broadly agree here, little valuation tension. A fairly wide model range (1,309 KRW to 3,040 KRW) leaves room in how you read the outcome.
Key figures of Daishin Balance No.6 Special Purpose Acquisition Co. Ltd
How large is the market capitalisation of Daishin Balance No.6 Special Purpose Acquisition Co. Ltd (307750)?
The market capitalisation of Daishin Balance No.6 Special Purpose Acquisition Co. Ltd is 113B KRW (≈ $83.0M). The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of Daishin Balance No.6 Special Purpose Acquisition Co. Ltd (307750)?
The price-to-sales ratio of Daishin Balance No.6 Special Purpose Acquisition Co. Ltd is 0.87 (last twelve months). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What is the dividend yield of Daishin Balance No.6 Special Purpose Acquisition Co. Ltd (307750)?
The dividend yield of Daishin Balance No.6 Special Purpose Acquisition Co. Ltd is 0.4%. Yearly dividend relative to the share price. 3% pays 3 per 100 invested. Below: how much of profit is used for it.
What is the net margin of Daishin Balance No.6 Special Purpose Acquisition Co. Ltd (307750)?
The net margin of Daishin Balance No.6 Special Purpose Acquisition Co. Ltd is −3.3% (fiscal year 2025). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of Daishin Balance No.6 Special Purpose Acquisition Co. Ltd (307750)?
The return on equity (ROE) of Daishin Balance No.6 Special Purpose Acquisition Co. Ltd is −7.9% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of Daishin Balance No.6 Special Purpose Acquisition Co. Ltd (307750)?
On an EBIT basis the return on assets of Daishin Balance No.6 Special Purpose Acquisition Co. Ltd is 1.6% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of Daishin Balance No.6 Special Purpose Acquisition Co. Ltd (307750)?
The operating margin of Daishin Balance No.6 Special Purpose Acquisition Co. Ltd is 7.7% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at Daishin Balance No.6 Special Purpose Acquisition Co. Ltd (307750)?
Revenue at Daishin Balance No.6 Special Purpose Acquisition Co. Ltd is growing −9.4% versus a year earlier (3y avg +8.1%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How fast are earnings growing at Daishin Balance No.6 Special Purpose Acquisition Co. Ltd (307750)?
Earnings per share at Daishin Balance No.6 Special Purpose Acquisition Co. Ltd are growing −77.8% versus a year earlier. How much earnings per share grew versus a year earlier.
How much net debt does Daishin Balance No.6 Special Purpose Acquisition Co. Ltd (307750) carry?
The net debt of Daishin Balance No.6 Special Purpose Acquisition Co. Ltd is 37.5B KRW (fiscal year 2025, ≈ 5.0 yrs of FCF). Debt minus cash on hand. The note shows how many years of free cash flow could in theory pay it off.
Free · no account needed
Watch Daishin Balance No.6 Special Purpose Acquisition Co. Ltd in the live analysis
One click puts Daishin Balance No.6 Special Purpose Acquisition Co. Ltd on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 35,000+ stock screener. You can also try 14 days of Pro there, no card.
